Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 32Pancreatic Neoplasms 28Colonic Neoplasms 24Stomach Neoplasms 19Neoplasm Metastasis 15Neoplasms 13Esophageal Neoplasms 10Breast Neoplasms 7Head and Neck Neoplasms 6Recurrence 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Lymphoma, Large B-Cell, Diffuse 4Carcinoma, Hepatocellular 4Ovarian Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2

Interventions

Flow Cytometry 2talactoferrin alfa 1perifosine 1cabozantinib 1antineoplaston AS 2-1 1antineoplaston A10 1alovudine 1alectinib 1Vorinostat 1Trastuzumab 1Tissue Array Analysis 1Taxes 1Sunitinib 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Paclitaxel 1Oxaliplatin 1Oligonucleotide Array Sequence Analysis 1Microarray Analysis 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fluorescent Antibody Technique 1Everolimus 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Salivary Gland Neoplasms × Oxaliplatin × Clear all
NCT00101075 2017-02-27

Title XELOX FOR SALIVARY GLAND CANCERS

Dana-Farber Cancer Institute

Phase 2 Terminated
9 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡